We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+16.73%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$7.31B
AUM Growth
+$1.27B
Cap. Flow
+$483M
Cap. Flow %
6.6%
Top 10 Hldgs %
32.03%
Holding
355
New
109
Increased
77
Reduced
150
Closed
13

Top Buys

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$69.4M
2
RBLX icon
Roblox
RBLX
+$67M
3
ADBE icon
Adobe
ADBE
+$48.4M
4
ANET icon
Arista Networks
ANET
+$47.4M
5
EPAM icon
EPAM Systems
EPAM
+$29M

Top Sells

Rank Stock Value
1
RGEN icon
Repligen
RGEN
+$30M
2
MBLY icon
Mobileye
MBLY
+$26.6M
3
CALX icon
Calix
CALX
+$15.7M
4
HUBS icon
HubSpot
HUBS
+$15.7M
5
DEN
Denbury Inc.
DEN
+$15.7M

Sector Composition

Rank Sector Weight
1 Technology 32.88%
2 Consumer Discretionary 19.89%
3 Healthcare 16.44%
4 Communication Services 10%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDXS icon
301
Codexis
CDXS
$153M
-615,323
Closed -$2.55M
FSLY icon
302
Fastly Inc
FSLY
$3.87B
-50,076
Closed -$889K
GWRE icon
303
Guidewire Software
GWRE
$12.4B
-10,331
Closed -$848K
LESL icon
304
Leslie's
LESL
$4.37M
-3,538
Closed -$779K
MGPI icon
305
MGP Ingredients
MGPI
$308M
-20,253
Closed -$1.96M
OXY icon
306
Occidental Petroleum
OXY
$63.5B
-5,289
Closed -$330K
PLMR icon
307
Palomar
PLMR
$3.64B
-41,938
Closed -$2.31M
UTHR icon
308
United Therapeutics
UTHR
$21.5B
-7,140
Closed -$1.6M
VIRX
309
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-160,515
Closed -$255K
AXNX
310
DELISTED
Axonics, Inc. Common Stock
AXNX
-19,256
Closed -$1.05M
NEX
311
DELISTED
NexTier Oilfield Solutions Inc.
NEX
-31,537
Closed -$251K
VECT
312
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
-56,137
Closed -$478K
APEN
313
DELISTED
Apollo Endosurgery, Inc.
APEN
-371,653
Closed -$3.69M
EAR
314
DELISTED
HEARUSA INC
EAR
$0 ﹤0.01%
+375
New
DSL
315
DELISTED
DOWNEY FINANCIAL CORP(HLDG CO)
DSL
$0 ﹤0.01%
+200
New
SVN
316
DELISTED
SUN-TIMES MEDIA GROUP INC.
SVN
$0 ﹤0.01%
+650
New
PTA
317
DELISTED
PENN TREATY AMERICAN CORPORATION NEW
PTA
$0 ﹤0.01%
+125
New

Similar funds

Gilder Gagnon Howe & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Gilder Gagnon Howe & Co held 355 positions worth $7.31B, up 21% from $6.04B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Gilder Gagnon Howe & Co deployed $483M of net new capital in Q2 2023, opening 109 new positions and adding to 77 existing holdings. Its largest new stake was Intel: 532,525 shares worth $17.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Repligen, an estimated $30M trimmed.

  • Gilder Gagnon Howe & Co's largest Q2 2023 buy was Intel: 532,525 shares worth $17.8M.
  • Gilder Gagnon Howe & Co added most to Datadog in Q2 2023, an estimated $69.4M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2023 reduction was Repligen, cutting an estimated $30M.
  • Gilder Gagnon Howe & Co fully exited Apollo Endosurgery, Inc. in Q2 2023, selling an estimated $3.69M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 32% of its $7.31B portfolio in Q2 2023.
  • Gilder Gagnon Howe & Co opened 109 new positions and closed 13 in Q2 2023.
  • Gilder Gagnon Howe & Co's portfolio value rose 21% quarter-over-quarter to $7.31B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2023, filed 14 Aug 2023.